<DOC>
	<DOCNO>NCT00272701</DOCNO>
	<brief_summary>The purpose study assess PPI treat GERD patient insufficient symptom control benefit change management provide efficient acid secretion inhibition 4 week , evaluation esomeprazole 40 mg compare pre-study PPI treatment .</brief_summary>
	<brief_title>Esomeprazole PPI Failures - IMPROVE</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Provision inform consent Male female , age 1865 year History GERD symptom , least , six month prior enrolment PPI maintenance treatment last 30 day prior enrolment Heartburn predominant GERD symptom , judge investigator Persisting GERD symptom past 7 day prior visit 1 , judge patient either : 4 day mild symptom ( i.e . awareness sign symptom , easily tolerate ) 2 day moderate ( i.e . discomfort sufficient cause interference normal activity ) severe symptom ( i.e . incapacitating , inability perform normal activity ) Any treatment esomeprazole 30 day prior enrolment History esophageal , gastric duodenal surgery , except simple closure ulcer Current historical evidence follow diseases/conditions , judge investigator : ZollingerEllison syndrome , Primary esophageal motility disorder , i.e . achalasia , scleroderma , primary esophageal spasm , Gastric duodenal ulcer within last three month , Malabsorbtion Malignancy concomitant disease poor prognosis may interfere assessment study Unstable diabetes mellitus . Stable diabetes control diet , oral agent insulin acceptable Patients severe disease disorder may interfere conduct study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2007</verification_date>
</DOC>